Adaptive Biotechnologies Posts Q2 2025 Financial Results
05 Aug 2025 //
GLOBENEWSWIRE
Adaptive Bio Reports Fourth Quarter and Full Year 2023 Financial Results
14 Feb 2024 //
GLOBENEWSWIRE
Adaptive Announces New Data Highlighting the Clinical Relevance of MRD Testing
09 Dec 2023 //
GLOBENEWSWIRE
Adaptive Announces Collaboration to Measure Minimal Residual Disease
07 Nov 2023 //
GLOBENEWSWIRE
Adaptive to Participate in the Morgan Stanley 21st Annual Conference
30 Aug 2023 //
GLOBENEWSWIRE
Adaptive Highlights Data at ASCO and EHA Underscoring the clonoSEQ Assay Impact
02 Jun 2023 //
GLOBENEWSWIRE
Adaptive to Participate in 2023 RBC Capital Markets Global Healthcare Conference
12 May 2023 //
GLOBENEWSWIRE
Adaptive to Participate in the BofA Securities 2023 Healthcare Conference
25 Apr 2023 //
GLOBENEWSWIRE
Adaptive to Participate in the 43rd Annual Cowen Healthcare Conference
27 Feb 2023 //
GLOBENEWSWIRE
Adaptive Reports Fourth Quarter and Full Year 2022 Financial Results
14 Feb 2023 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Conference
27 Dec 2022 //
GLOBENEWSWIRE
Adaptive Highlights Data Showcasing the Utility of clonoSEQ MRD Testing
10 Dec 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts
05 Dec 2022 //
GLOBENEWSWIRE
Adaptive Announces Launch of clonoSEQ® to Assess (MRD) Patients(DLBCL, ctDNA)
01 Dec 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Participate in Piper Sandler Healthcare Conference
21 Nov 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
03 Nov 2022 //
PRESS RELEASE
Adaptive Announces Partnership with Epic to Increase Access to (MRD)
11 Oct 2022 //
GLOBENEWSWIRE
Adaptive to Report Third Quarter of 2022 Financial Results on Novr 3, 2022
05 Oct 2022 //
GLOBENEWSWIRE
Vaccinia virus- vaccines mount robust immune response against monkeypox virus
12 Sep 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Participate in the Morgan Stanley Global Healthcare
02 Sep 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results
03 Aug 2022 //
GLOBENEWSWIRE
Adaptive Bio to Report Q2 of 2022 Financial Results on August 3, 2022
08 Jul 2022 //
GLOBENEWSWIRE
Adaptive Biotech Launches T-Detect Lyme for the Detection of Early Lyme Disease
15 Jun 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies Included in Key Abstracts at ASCO 2022
02 Jun 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports First Quarter 2022 Financial Results
04 May 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Present at the BofA Securities 2022 Conference
02 May 2022 //
GLOBENEWSWIRE
Adaptive Bio to Report First Quarter Financial Results on May 4, 2022
05 Apr 2022 //
GLOBENEWSWIRE
Adaptive Bio Appoints Tycho Peterson as CFO
09 Mar 2022 //
GLOBENEWSWIRE
Adaptive Bio to Present at the 42nd Annual Cowen Healthcare Conference
02 Mar 2022 //
GLOBENEWSWIRE
Adaptive Bio Shows New Data Demonstrating ImmunoSEQ Technology
18 Feb 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports Q4 and Full Year 2021 Financial Results
15 Feb 2022 //
GLOBENEWSWIRE
Adaptive Bio Announces Unaudited 2021 Revenue Results & CFO Transition
10 Jan 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Present Virtually at the 40th Annual J.P. Morgan
29 Dec 2021 //
GLOBENEWSWIRE
Adaptive Biotechnologies Announces New Data Demonstrating the Benefit
13 Dec 2021 //
GLOBENEWSWIRE
Adaptive Biotechnologies & Collaborators to Present More than 30 Abstracts
02 Dec 2021 //
GLOBENEWSWIRE
Adaptive Receives Updated Medicare Coverage for its MRD Assay, clonoSEQ
11 Nov 2021 //
GLOBENEWSWIRE
Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating
02 Oct 2021 //
GLOBENEWSWIRE
Grand Opening of Adaptive Biotechnologies` New Waterfront Headquarters
21 Sep 2021 //
PRNEWSWIRE
Adaptive Biotechnologies to Present New SARS-CoV-2 Data
16 Sep 2021 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Report Q2 Financial Results on August 4, 2021
12 Jul 2021 //
GLOBENEWSWIRE
New Study Published in Nature Provides Further Evidence on COVID
09 Jun 2021 //
GLOBENEWSWIRE
Single-Shot COVID-19 Vaccine Generates Robust Immune Responses Against Variants
09 Jun 2021 //
EUREKA ALERT
Adaptive Phage Therapeutics Initiates Phase 1/2 Trial of PhageBank™
03 Jun 2021 //
BUSINESSWIRE
US FDA grants EUA to Adaptive Biotechnologies’ T-Detect Covid to confirm
07 Mar 2021 //
PHARMABIZ
Adaptive Reports Fourth Quarter and Full Year 2020 Financial Results
24 Feb 2021 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Collaborate with AZ in Mapping the Immune Response
11 Jan 2021 //
BIOSPACE
Adaptive Biotechnologies: AI can ‘translate’ immune system
27 May 2020 //
OUTSOURCE-PHARMA
Amgen And Adaptive Biotechnologies To Participate In Webinar On COVID-19
07 Apr 2020 //
PR NEWSWIRE
Biotech Pioneer Amgen Joins Hunt for Coronavirus Drug
04 Apr 2020 //
PRESS RELEASE
Adaptive Biotechnologies and Microsoft expand partnership
20 Mar 2020 //
PRESS RELEASE
Adaptive Biotechnologies And Microsoft Expand Partnership
20 Mar 2020 //
REUTERS
Amgen picks Adaptive`s MRD diagnostic for its blood cancer work
18 Sep 2019 //
FIERCE BIOTECH
Adaptive Biotechnologies stock tumbles after first earnings report since IPO
14 Aug 2019 //
CNBC
Adaptive Biotechnologies Announces Closing of IPO
01 Jul 2019 //
GLOBE NEWSWIRE
4 Biotech IPOs, and 2 Are Unicorns
27 Jun 2019 //
BIOSPACE
Immune cell-sequencer Adaptive Biotechnologies plans $200M IPO
17 Jun 2019 //
FIERCE BIOTECH

Market Place
Sourcing Support